{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:04:04Z","timestamp":1789153444182,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejphar.2024.176429","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T07:16:45Z","timestamp":1709018205000},"page":"176429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model"],"prefix":"10.1016","volume":"969","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4141-3461","authenticated-orcid":false,"given":"Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linglin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.clnu.2016.05.010","article-title":"The 2015 ESPEN Sir David Cuthbertson lecture: inflammation as the driving force of muscle wasting in cancer","volume":"36","author":"Argiles","year":"2017","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ejphar.2024.176429_bib2","article-title":"Inter-tissue communication in cancer cachexia","author":"Argiles","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.176429_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"Aulino","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2015.02.014","article-title":"Ursolic acid ameliorates aging-metabolic phenotype through promoting of skeletal muscle rejuvenation","volume":"85","author":"Bakhtiari","year":"2015","journal-title":"Med. Hypotheses"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176429_bib5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4196\/kjpp.2017.21.6.651","article-title":"Ursolic acid supplementation decreases markers of skeletal muscle damage during resistance training in resistance-trained men: a pilot study","volume":"21","author":"Bang","year":"2017","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.ejphar.2024.176429_bib6","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.ejphar.2024.176429_bib7","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib8","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176429_bib9","first-page":"479","article-title":"Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt\/mTOR\/FoxO3\u03b1 signaling pathway in C2C12 myotubes and mice","volume":"42","author":"Chen","year":"2019","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176429_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277061","article-title":"Ursolic acid regulates gut microbiota and corrects the imbalance of Th17\/Treg cells in T1DM rats","volume":"17","author":"Chen","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13619-022-00108-9","article-title":"Pathological features of tissues and cell populations during cancer cachexia","volume":"11","author":"Di Girolamo","year":"2022","journal-title":"Cell Regen."},{"key":"10.1016\/j.ejphar.2024.176429_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/601434","article-title":"Cancer cachexia: mechanisms and clinical implications","volume":"2011","author":"Donohoe","year":"2011","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176429_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy","volume":"461","author":"Foletta","year":"2011","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib16","doi-asserted-by":"crossref","first-page":"R698","DOI":"10.1152\/ajpregu.00039.2002","article-title":"Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle","volume":"283","author":"Frost","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176429_bib17","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1039\/D0FO00829J","article-title":"Ursolic acid alleviates hypercholesterolemia and modulates the gut microbiota in hamsters","volume":"11","author":"Hao","year":"2020","journal-title":"Food Funct."},{"issue":"10","key":"10.1016\/j.ejphar.2024.176429_bib18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1211\/jpp.60.10.0011","article-title":"The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models","volume":"60","author":"Kang","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.20463\/jenb.2019.0022","article-title":"Effects of ursolic acid on muscle mass and bone microstructure in rats with casting-induced muscle atrophy","volume":"23","author":"Kang","year":"2019","journal-title":"Journal of exercise nutrition & biochemistry"},{"issue":"2","key":"10.1016\/j.ejphar.2024.176429_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","article-title":"Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist","volume":"5","author":"Kazemi-Bajestani","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4196\/kjpp.2018.22.4.427","article-title":"Concurrent treatment with ursolic acid and low-intensity treadmill exercise improves muscle atrophy and related outcomes in rats","volume":"22","author":"Kim","year":"2018","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004973","article-title":"Inhibition of atrogin-1\/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo","volume":"4","author":"Lagirand-Cantaloube","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176429_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.shk.0000055237.25446.80","article-title":"Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle","volume":"19","author":"Lang","year":"2003","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib24","doi-asserted-by":"crossref","first-page":"R1165","DOI":"10.1152\/ajpregu.2000.279.4.R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176429_bib25","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3892\/ijo.2013.2101","article-title":"Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways","volume":"43","author":"Lin","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2024.176429_bib26","article-title":"Ursolic acid protects neurons in temporal lobe epilepsy and cognitive impairment by repressing inflammation and oxidation","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176429_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clnu.2020.06.004","article-title":"Ursolic acid has no additional effect on muscle strength and mass in active men undergoing a high-protein diet and resistance training: a double-blind and placebo-controlled trial","volume":"40","author":"Lobo","year":"2021","journal-title":"Clin. Nutr."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176429_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084256","article-title":"Skeletal and cardiac muscle disorders caused by mutations in genes encoding intermediate filament proteins","volume":"22","author":"Maggi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176429_bib29","article-title":"What role do inflammatory cytokines play in cancer cachexia?","volume":"14","author":"Malla","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2024.176429_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2016.09.005","article-title":"Skeletal and cardiac muscle pericytes: functions and therapeutic potential","volume":"171","author":"Murray","year":"2017","journal-title":"Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176429_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\"","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"24","key":"10.1016\/j.ejphar.2024.176429_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248981","article-title":"Ursolic acid analogs as potential therapeutics for cancer","volume":"27","author":"Panda","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031849","article-title":"Targeting gut microbiota in cancer cachexia: towards new treatment options","volume":"24","author":"Panebianco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176429_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-alpha and cancer cachexia: molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.176429_bib37","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib38","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.3892\/mmr.2016.5654","article-title":"Renoprotective effects of ursolic acid on ischemia\/reperfusion-induced acute kidney injury through oxidative stress, inflammation and the inhibition of STAT3 and NF-\u03baB activities","volume":"14","author":"Peng","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.21037\/apm.2018.07.06","article-title":"Anti-cytokines in the treatment of cancer cachexia","volume":"8","author":"Prado","year":"2019","journal-title":"Ann. Palliat. Med."},{"issue":"9","key":"10.1016\/j.ejphar.2024.176429_bib40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1089\/jmf.2017.0003","article-title":"Effect of ursolic acid on metabolic syndrome, insulin sensitivity, and inflammation","volume":"20","author":"Ram\u00edrez-Rodr\u00edguez","year":"2017","journal-title":"J. Med. Food"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-020-00288-6","article-title":"Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia","volume":"10","author":"Rausch","year":"2021","journal-title":"Oncogenesis"},{"issue":"22","key":"10.1016\/j.ejphar.2024.176429_bib42","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","article-title":"Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways","volume":"71","author":"Rodriguez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.ejphar.2024.176429_bib43","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of cancer cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176429_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4162\/nrp.2022.16.2.147","article-title":"Ursolic acid improves the indoxyl sulfate-induced impairment of mitochondrial biogenesis in C2C12 cells","volume":"16","author":"Sasaki","year":"2022","journal-title":"Nutr. Res. Prac."},{"issue":"5","key":"10.1016\/j.ejphar.2024.176429_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cytogfr.2015.07.004","article-title":"Interleukin-6: biology, signaling and strategies of blockade","volume":"26","author":"Schaper","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"10.1016\/j.ejphar.2024.176429_bib46","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.bcp.2013.03.006","article-title":"Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies","volume":"85","author":"Shanmugam","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.176429_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00109-011-0746-2","article-title":"Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice","volume":"89","author":"Shanmugam","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejphar.2024.176429_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6679316","article-title":"Ursolic acid regulates intestinal microbiota and inflammatory cell infiltration to prevent ulcerative colitis","volume":"2021","author":"Sheng","year":"2021","journal-title":"Journal of immunology research"},{"issue":"5","key":"10.1016\/j.ejphar.2024.176429_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285850","article-title":"Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: a study protocol (LUANA trial)","volume":"18","author":"Sousa","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176429_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104735","article-title":"Ursolic acid: a systematic review of its pharmacology, toxicity and rethink on its pharmacokinetics based on PK-PD model","volume":"147","author":"Sun","year":"2020","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.176429_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082378","article-title":"Ursolic acid alleviates cancer cachexia and prevents muscle wasting via activating SIRT1","volume":"15","author":"Tao","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jhn.12811","article-title":"Cancer cachexia: an overview of diagnostic criteria and therapeutic approaches for the accredited practicing dietitian","volume":"34","author":"van der Meij","year":"2021","journal-title":"J. Hum. Nutr. Diet. : the official journal of the British Dietetic Association"},{"issue":"6","key":"10.1016\/j.ejphar.2024.176429_bib55","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00520-012-1697-z","article-title":"Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients","volume":"21","author":"Wallengren","year":"2013","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejphar.2024.176429_bib56","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.biopha.2017.11.032","article-title":"Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats","volume":"97","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176429_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.597675","article-title":"Inflammation and skeletal muscle wasting during cachexia","volume":"11","author":"Webster","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2024.176429_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112267","article-title":"The combination of ursolic acid and empagliflozin relieves diabetic nephropathy by reducing inflammation, oxidative stress and renal fibrosis","volume":"144","author":"Wu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.ejphar.2024.176429_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228592","article-title":"Cachexia, a systemic disease beyond muscle atrophy","volume":"21","author":"Wyart","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176429_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-022-01626-7","article-title":"Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study","author":"Xie","year":"2022","journal-title":"Inflamm. Res. : official journal of the European Histamine Research Society"},{"issue":"11","key":"10.1016\/j.ejphar.2024.176429_bib61","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.phymed.2013.04.020","article-title":"Parthenolide from Parthenium integrifolium reduces tumor burden and alleviate cachexia symptoms in the murine CT-26 model of colorectal carcinoma","volume":"20","author":"Yang","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2024.176429_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-022-00752-w","article-title":"Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia","author":"Yeom","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib63","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/10408398.2016.1203755","article-title":"Ursolic acid, a potential anticancer compound for breast cancer therapy","volume":"58","author":"Yin","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.ejphar.2024.176429_bib64","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jcsm.12162","article-title":"Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease","volume":"8","author":"Yu","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ejphar.2024.176429_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13395-021-00274-5","article-title":"Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release","volume":"11","author":"Zhou","year":"2021","journal-title":"Skeletal Muscle"},{"issue":"4","key":"10.1016\/j.ejphar.2024.176429_bib66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924001171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924001171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T05:13:27Z","timestamp":1734412407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924001171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":66,"alternative-id":["S0014299924001171"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176429","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176429"}}